Review
Oct 2026
Immuno-Oncology: New Insights into Targets and Therapies.
Current active clinical trials evaluate new immune checkpoints, including lymphocyte activation gene 3, T cell immunoreceptor with Ig and ITIM domains, and killer Ig-like receptor 2DL1/2L3.
S. Schokrpur, M. G. White, C. Roland et al.
· Hematology/Oncology Clinics... · 0 citations